Quadrature Capital Ltd lowered its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 68.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,981 shares of the company's stock after selling 61,078 shares during the quarter. Quadrature Capital Ltd's holdings in Envista were worth $553,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Envista during the third quarter worth approximately $31,000. GAMMA Investing LLC raised its holdings in Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock worth $35,000 after purchasing an additional 726 shares in the last quarter. Huntington National Bank lifted its position in Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after purchasing an additional 949 shares during the period. Blue Trust Inc. increased its position in Envista by 69.7% during the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock worth $39,000 after purchasing an additional 804 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its position in Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock worth $43,000 after purchasing an additional 728 shares during the period.
Envista Trading Up 0.6 %
NVST traded up $0.12 during trading on Monday, hitting $20.01. 1,630,398 shares of the company's stock were exchanged, compared to its average volume of 2,376,417. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $25.64. The stock has a 50 day moving average price of $19.98 and a 200 day moving average price of $18.37. The firm has a market cap of $3.44 billion, a P/E ratio of -2.56, a price-to-earnings-growth ratio of 2.77 and a beta of 1.32. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42.
Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The company had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. During the same period last year, the company posted $0.43 earnings per share. The firm's revenue was down 4.8% compared to the same quarter last year. As a group, analysts expect that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on NVST. Evercore ISI upped their price objective on Envista from $18.00 to $23.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Leerink Partnrs upgraded shares of Envista from a "strong sell" rating to a "hold" rating in a research note on Thursday, October 31st. Wells Fargo & Company began coverage on shares of Envista in a research report on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 target price on the stock. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a research report on Thursday, October 31st. Finally, Mizuho started coverage on Envista in a report on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 price target on the stock. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $20.65.
View Our Latest Stock Report on Envista
Envista Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.